次世代エネルギー産業・グリーン経済の国際リサーチ情報サイト

医薬品偽造防止技術の世界市場2015-2025年

Pharmaceutical Anti-counterfeiting Technologies: Market Analysis and Forecasts 2015-2025

出版元:Visiongain(英国)出版元情報LinkIcon
発行年:2014年12月
定価 Single User License(1名様ライセンス) 1,799 GBP(英国ポンド) / Department License(5名様ライセンス) 2,999GBP/ Site License 4,999GBP / Global Site License 6,999GBP
ご請求は円換算(お見積り日TTSレート)となります。
納品形態:PDF by Email (※デジタル著作権管理/DRM設定有り)
当調査レポートは英文242ページになります。
商品コード:VGN317

お問い合わせ、お見積りのリクエストは下のボタンをクリックしてご入力ください。



【レポート紹介】
医薬品偽造防止技術の世界市場は、2015年に34億ドル規模に達し、2025年にかけて力強い成長が予測されます。偽造医薬品事例の増加、各国政府当局の規制、アメリカ食品医薬品局(FDA)の取組み、関連技術の進化、そしてRFID市場の急成長などは今後10年間の成長促進要因となるでしょう。地域的には先進国、新興国ともに成長基調ですが、特に米国、中国、インド、メキシコ、ブラジルで高成長が予測されます。
当レポートでは、医薬品偽造防止技術の詳細な市場予測(技術セグメント別、国別)、専門家オピニオンインタビュー、業界動向分析、リーディング企業動向などを織り交ぜ、概略以下の構成でお届けいたします。

【レポート構成概要】
・医薬品偽造防止技術の世界市場予測2015-2025年
・全242ページ、126個のデータ表、グラフ類で分析定量化と可視化
・市場の詳細売上予測、成長率、市場シェア情報
・業界専門家オピニオンインタビュー:
- Dave Coons, VP of Advanced Markets and Technology; Laurie Eldridge-Shanaman, Director, Global Healthcare Practice; Clive Hohberger; Previously VP of Technology Development at Zebra Technologies
- Ryon Packer, Chief Marketing Officer and General Manager at Authentix
- Dr Michael Hogan, Vice President of Life Sciences at Applied DNA Sciences
- Mike Messmer, General Manager at NovaVision
- Dr Fred Jordan, Chief Executive Officer at AlpVision
- Spokesperson from a leading anti-counterfeiting technologies company based in the US

・技術セグメント別市場予測2015-2025年VGN317_Pharmaceutical Anti-counterfeiting Technologies Market Analysis and Forecasts 2015-2025 Cover.jpg
• バーコード Barcodes
• RFID
• ホログラムHolograms/OVD
• タガントTaggants
• その他偽造防止技術

・主要国、地域別市場予測2015-2025年
• 米国
• EU5カ国(ドイツ、フランス、英国、イタリア、スペイン合計データ)
• 日本
• 中国
• インド
• ブラジル
• ロシア
• メキシコ
• その他地域Rest of the World

・リーディング企業16社プロフィール、主要偽造防止技術、業績、新製品、提携動向など
• 3M
• Alien Technology
• AlpVision
• Angstrom Technologies
• Authentix
• Avery Dennison
• Colorcon
• Covectra
• Everest Holovisions
• InkSure Technologies
• Intermec
• Multi Packaging Solutions
• ThermoFisher Scientific
• TruTag Technologies
• UPM Raflatac
• Zebra Technologies

・市場動向(諸論点)
• 偽造医薬品事件の増加を背景とする医薬品偽造防止技術への需要拡大
• 主要国市場におけるシリアル番号化(Serialisation)の政府当局要件
• ブランドネームと収益の保護
• 偽造防止技術の採用コスト
• サプライチェーンへの影響
• 医薬品のオンライン市場

Visiongain is a trading partner with the US Federal Government.
【レポート詳細目次、データ項目一覧(List of Tables)は当ページ下を参照ください】

英文詳細目次(table of contents)

【原文詳細目次】

Pharmaceutical Anti-counterfeiting Technologies: Market Analysis and Forecasts 2015-2025

Table of Contents

1. Report Overview

1.1 Pharmaceutical Anti-counterfeiting Technologies Market Highlights
1.2 World Pharmaceutical Anti-counterfeiting Technologies Market Breakdowns by Technology and Region
1.3 Why You Should Read This Report
1.4 How This Report Delivers
1.5 Key Questions Answered by This Analytical Report
1.6 Who is This Report For?
1.7 Methodology
1.8 Frequently Asked Questions (FAQ)
1.9 Associated Visiongain Reports
1.10 About Visiongain

2. Introduction to Pharmaceutical Counterfeiting

2.1 Drug Counterfeiting: A Thorn in the Side of the Pharma Industry
2.1.1 Regional Differences Hindering Information Exchange
2.1.2 Rising Worldwide Counterfeiting Incidents
2.1.3 Highest Counterfeiting Incidents in Asia and Europe in 2013
2.2 What are the Most Commonly Counterfeited Drugs?
2.3 Types of Counterfeit Drugs
2.3.1 Substandard Pharmaceutical Products as Counterfeits
2.3.2 Global Outsourcing of Active Pharmaceutical Ingredients (APIs)
2.3.2.1 Heparin Contamination
2.3.2.2 Stricter Enforcement needed for API Control
2.4 Why are Drugs Counterfeited?
2.5 Methods of Producing Pharmaceutical Counterfeits
2.5.1 Moving Counterfeits into the Pharmaceutical Supply Chain
2.5.2 Corruption Within the Pharmaceutical Distribution System
2.6 The Internet and Its Role in Pharmaceutical Counterfeiting
2.6.1 Online Pharmacies: A Cheap Distribution System for Pharma Counterfeits
2.6.2 Legal Online Pharmacies: A Convenient and Quick Way of Dispensing Medication
2.6.3 Verifying the Authenticity of Online Pharmacies
2.7 Pharmaceutical Counterfeiting: The Global Costs
2.7.1 The Impact of Pharmaceutical Counterfeiting on Consumers
2.7.2 The Impact of Counterfeiting on Healthcare Providers
2.7.3 The Impact of Counterfeiting on Pharma Manufacturers
2.7.4 The Impact of Pharmaceutical Counterfeiting on Governments
2.7.5 The Impact of Counterfeiting on the Global Pharmaceutical Industry
2.8 Operation Pangea: Europol’s Fight Against Counterfeiting
2.8.1 Legislative Deficiencies Aiding Counterfeiting Operations
2.9 Factors Fuelling Pharmaceutical Counterfeiting
2.9.1 An Erratic Supply or Shortage of Drugs Promotes Counterfeiting
2.9.2 Price Differentials and High Price Medicines Drive People to Cheaper Counterfeit Alternatives
2.9.3 Drug Misuse Creates a Market for Counterfeiting
2.9.4 Trade through Free-Trade Zones/Free Ports Is an Important Route for Counterfeiters
2.9.5 The Trade of Pharmaceuticals through Several Intermediaries Helps Hide Counterfeit Drugs
2.9.6 Counterfeiters Target Developed Markets
2.9.7 Parallel Trade – a Counterfeiting Route in Europe
2.10 Leading Anti-counterfeiting Technologies and Applications
2.10.1 Passive Anti-counterfeiting Technologies
2.10.1.1 Holograms
2.10.1.2 Security Inks
2.10.1.3 Overt and Hidden Imaging
2.10.1.4 Visual Inspection as the First Line of Defence Against Drug Counterfeiting
2.10.2 Active Anti-counterfeiting Technologies
2.10.2.1 Radio Frequency Identification (RFID)
2.10.2.1 Taggants
2.10.3 Mass Encoding Technologies
2.10.3.1 Digital Mass Serialisation Technology (DMS)
2.10.3.2 Digital Mass Encryption (DME)
2.10.3.3 Barcodes

3. Pharmaceutical Anti-counterfeiting Technologies: World Market 2015-2025

3.1 World Pharmaceutical Anti-counterfeiting Technologies Market in 2013 and 2014
3.1.1 Breakdown of the World Pharmaceutical Anti-counterfeiting Technologies Market by Technology in 2013 and 2014
3.2 World Pharmaceutical Anti-counterfeiting Technologies Market: Sales Forecast 2015-2025
3.2.1 World Pharmaceutical Anti-counterfeiting Technologies Market: Sales Forecast 2013-2019
3.2.2 World Pharmaceutical Anti-counterfeiting Technologies Market: Sales Forecast 2019-2025
3.3 RFID Lead the World Pharmaceutical Anti-counterfeiting Technologies Market
3.4 Market Attractiveness Forecasts of Leading Pharmaceutical Anti-counterfeiting Technologies in 2019 and 2025
3.5 How Will Segmental Market Shares Change to 2025?
3.6 World Pharmaceutical Anti-counterfeiting Technologies Market: Drivers and Restraints 2015-2025

4. Leading National Markets 2015-2025

4.1 Geographical Breakdown of the World Pharmaceutical Anti-counterfeiting Technologies Market in 2013 and 2014
4.2 World Pharmaceutical Anti-counterfeiting Technologies Market: National Markets Forecast 2015-2025
4.2.1 Market Attractiveness Forecasts of Leading Pharmaceutical Anti-counterfeiting National Markets in 2019 and 2025
4.2.1.1 Market Attractiveness Forecasts of Developed Countries in 2019 and 2025
4.2.1.2 Market Attractiveness Forecasts of Emerging Countries in 2019 and 2025
4.2.2 How Will National Market Shares Change to 2025?
4.3 US Pharmaceutical Anti-counterfeiting Technologies Market in 2013 and 2014
4.3.1 US Pharmaceutical Anti-counterfeiting Technologies Market Forecast 2015-2025
4.3.2 US Pharmaceutical Anti-counterfeiting Technologies Market: Trends and Developments
4.3.2.1 Drug Supply Chain Security Act of 2013
4.4 EU5 Pharmaceutical Anti-counterfeiting Technologies Market in 2013 and 2014
4.4.1 EU5 Pharmaceutical Anti-counterfeiting Technologies Market Forecast 2015-2025
4.4.2 EU5 Pharmaceutical Anti-counterfeiting Technologies Market: Trends and Developments
4.4.2.1 EU Enforcement of Drug Serialisation by 2016
4.5 Japanese Pharmaceutical Anti-counterfeiting Technologies Market in 2013 and 2014
4.5.1 Japanese Pharmaceutical Anti-counterfeiting Technologies Market Forecast 2015-2025
4.5.2 Japanese Pharmaceutical Anti-counterfeiting Technologies Market: Trends and Developments
4.5.2.1 Japan’s Uptake of Anti-counterfeiting Technologies
4.6 Chinese Pharmaceutical Anti-counterfeiting Technologies Market in 2013 and 2014
4.6.1 Chinese Pharmaceutical Anti-counterfeiting Technologies Market Forecast 2015-2025
4.6.2.1 Chinese Anti-Counterfeiting Measures From Past to Present
4.7 Indian Pharmaceutical Anti-counterfeiting Technologies Market in 2013 and 2014
4.7.1 Indian Pharmaceutical Anti-counterfeiting Technologies Market Forecast 2015-2025
4.7.2 Indian Pharmaceutical Anti-counterfeiting Technologies Market: Trends and Developments
4.7.2.1 Collaboration with the WHO will Help Regain Consumer Confidence in Pharma Products
4.8 Brazilian Pharmaceutical Anti-counterfeiting Technologies Market in 2013 and 2014
4.8.1 Brazilian Pharmaceutical Anti-counterfeiting Technologies Market Forecast 2015-2025
4.8.2 Brazilian Pharmaceutical Anti-counterfeiting Technologies Market: Trends and Developments
4.8.2.1 Brazilian Anti-Counterfeiting Measures From Past to Present
4.9 Russian Pharmaceutical Anti-counterfeiting Technologies Market in 2013 and 2014
4.9.1 Russian Pharmaceutical Anti-counterfeiting Technologies Market Forecast 2015-2025
4.9.2 Russian Pharmaceutical Anti-counterfeiting Technologies Market: Trends and Developments
4.9.2.1 Russian Anti-Counterfeiting Measures From Past to Present
4.10 Mexican Pharmaceutical Anti-counterfeiting Technologies Market in 2013 and 2014
4.10.1 Mexican Pharmaceutical Anti-counterfeiting Technologies Market Forecast 2015-2025
4.10.2 Mexican Pharmaceutical Anti-counterfeiting Technologies Market: Trends and Developments
4.10.2.1 Mexico Signs the ACTA

5. Pharmaceutical Barcodes Market 2015-2025

5.1 Barcodes as Anti-counterfeiting Technology
5.2 Pharmaceutical Barcodes Market in 2013 and 2014
5.3 Pharmaceutical Barcodes Market: Sales Forecast 2015-2025
5.4 Pharmaceutical Barcodes Market: Drivers and Restraints 2015-2025

6. Pharmaceutical RFID Market 2015-2025

6.1 RFID as Anti-counterfeiting Technology
6.2 Pharmaceutical RFID Market in 2013 and 2014
6.3 Pharmaceutical RFID Market: Sales Forecast 2015-2025
6.4 Pharmaceutical RFID Market: Drivers and Restraints 2015-2025
6.4.1 Driver: Benefits of RFID Track-and-Trace in the Pharma Industry
6.4.2 Driver: Brand Protection and Prevention of Revenue Loss
6.4.3 Restraint: Threat of Information Leakage with Passive RFID Tags
6.4.4 Restraint: High Initial Outlay of RFID Systems

7. Pharmaceutical Taggants Market 2015-2025

7.1 Taggants as Anti-counterfeiting Technology
7.1.1 Types of Taggants and Their Authentication Methods
7.2 Pharmaceutical Taggants Market in 2013 and 2014
7.3 Pharmaceutical Taggants Market: Sales Forecast 2015-2025
7.4 Pharmaceutical Taggants Market: Drivers and Restraints 2015-2025

8. Pharmaceutical Holograms/OVD Market 2015-2025

8.1 Holograms/OVD as Anti-counterfeiting Technology
8.2 Pharmaceutical Holograms/OVD Market in 2013 and 2014
8.3 Pharmaceutical Holograms/OVD Market: Sales Forecast 2015-2025
8.4 Pharmaceutical Holograms/OVD Market: Drivers and Restraints 2015-2025
8.5 Other Pharmaceutical Anti-counterfeiting Technologies Market: Sales Forecast 2015-2025

9. Leading Companies in the Pharmaceutical Anti-counterfeiting Technologies Market

9.1 Leading Pharmaceutical Anti-counterfeiting Technology Manufacturers by Segment in 2014
9.2 3M At a Glance
9.2.1 3M: Pharma Anti-counterfeiting Technology Portfolio
9.3 Alien Technology At a Glance
9.3.1 Alien Technology: Pharma Anti-counterfeiting Technology Portfolio
9.3.2 Alien Technology: Recent Developments
9.3.2.1 New Partnership and Securing Investments
9.3.2.2 New Products Launch
9.4 AlpVision At a Glance
9.4.1 AlpVision: Pharma Anti-counterfeiting Technology Portfolio
9.4.3 AlpVision: Recent Developments
9.4.3.1 Integration of Phone Applications Important for Future Growth
9.5 Angstrom Technologies At a Glance
9.5.1 Angstrom Technologies: Pharma Anti-counterfeiting Technology Portfolio
9.6 Authentix At a Glance
9.6.1 Authentix: Pharma Anti-counterfeiting Technology Portfolio
9.6.1.1 Product-specific Track-and-Trace Solutions
9.6.1.2 Packaging Solutions
9.7 Avery Dennison At a Glance
9.7.1 Avery Dennison: Pharma Anti-counterfeiting Technology Portfolio
9.7.2 Avery Dennison: Financial Overview
9.8 Colorcon At a Glance
9.8.1 Colorcon: Pharma Anti-counterfeiting Technology Portfolio
9.8.1.1 Colorcon’s Taggants: On-Dose ID
9.8.2 Colorcon: Recent Developments
9.8.2.1 Investing For the Future in South Asia
9.9 Covectra At a Glance
9.9.1 Covectra: Pharma Anti-counterfeiting Technology Portfolio
9.9.1.1 Covectra’s Authenti-Track System for Product Tracing
9.9.1.2 Covectra’s ControlTrack System for Combating Opioid Drug Diversion
9.9.2 Covectra: Recent Developments
9.9.2.1 Establishing European Presence
9.10 Everest Holovisions At a Glance
9.11 InkSure Technologies At a Glance
9.11.1 InkSure Technologies: Pharma Anti-counterfeiting Technology Portfolio
9.11.2 InkSure Technologies: Financial Overview
9.11.3 InkSure Technologies: Recent Developments
9.11.3.1 InkSure Completes Purchase Agreement to Sell Assets
9.12 Intermec At a Glance
9.12.1 Intermec: Pharma Anti-counterfeiting Technology Portfolio
9.12.2 Intermec: Financial Overview
9.12.3 Intermec: Recent Developments
9.12.3.1 Acquisition of Intermec by Honeywell
9.13 Multi Packaging Solutions At a Glance
9.13.1 MPS: Pharma Anti-counterfeiting Technology Portfolio
9.13.2 MPS: Recent Developments
9.13.2.1 MPS’s Mergers and Acquisitions
9.14 ThermoFisher Scientific At a Glance
9.14.1 ThermoFisher Scientific: Pharma Anti-counterfeiting Technology Portfolio
9.14.1.1 ThermoFisher Scientific’s TruScan Technology
9.14.2 ThermoFisher Scientific: Financial Overview
9.14.3 ThermoFisher Scientific: Recent Developments
9.14.3.1 ThermoFisher Scientific’s Mergers and Acquisitions
9.15 TruTag Technologies At a Glance
9.15.1 TruTag Technologies: Pharma Anti-counterfeiting Technology Portfolio
9.15.1.1 TruTag’s Silica Microtag Technology
9.15.2 TruTag Technologies: Recent Developments
9.15.2.1 Investment from WuXi PharmaTech
9.16 UPM Raflatac At a Glance
9.16.1 UPM Raflatac: Pharma Anti-counterfeiting Technology Portfolio
9.16.2 UPM Raflatac: Recent Developments
9.16.2.1 Smartrac Takeover of UPM Raflatac’s RFID Business
9.17 Zebra Technologies At a Glance
9.17.1 Zebra Technologies: Pharma Anti-counterfeiting Technology Portfolio
9.17.2 Zebra Technologies: Financial Overview
9.17.3 Zebra Technologies: Recent Developments
9.17.3.1 Zebra Acquire Enterprise Business from Motorola Solutions
9.17.3.2 Zebra Acquire Hart Systems
9.17.3.3 Zebra Launch of Zatar

10. Qualitative Analysis of the Pharmaceutical Anti-counterfeiting Technologies Market 2015-2025

10.1 SWOT Analysis of World Pharmaceutical Anti-counterfeiting Technologies Market 2015-2025
10.2 Strengths
10.2.1 Growing Interest from Pharmaceutical Companies in Tackling Counterfeiting
10.2.1.1 AstraZeneca
10.2.1.2 GlaxoSmithKline (GSK)
10.2.1.3 Johnson & Johnson (J&J)
10.2.1.4 Novartis
10.2.1.5 Pfizer
10.2.1.6 Sanofi
10.2.2 Organisations Promoting Awareness and Implementation of Anti-counterfeiting Solutions
10.2.2.1 Anti-counterfeiting and Product Protection Programme (A-CAPPP)
10.2.2.2 Anti-counterfeiting Group (ACG)
10.2.2.3 Brazil’s National Health Surveillance Agency (ANVISA)
10.2.2.4 Canadian Anti-counterfeiting Network (CACN)
10.2.2.5 Centre for Healthcare Supply Chain Research
10.2.2.6 European Alliance for Access to Safe Medicines (EAASM)
10.2.2.7 European Federation of Pharmaceutical Industries and Associations (EFPIA)
10.2.2.8 International Anti-counterfeiting Coalition (IACC)
10.2.2.9 International Authentication Association (IAA)
10.2.2.10 Pharmaceutical Security Institute (PSI)
10.2.3 Track-and-Trace Solutions Boosting Supply Chain Efficiency
10.2.4 New Technologies Providing More Comprehensive Anti-counterfeiting Protection
10.2.5 Litigation Proceedings over Counterfeit Products Affecting Profitability
10.3 Weaknesses
10.3.1 Lack of Standardisation Across the Industry Will Impede Technology Adoption
10.3.2 Insufficient Quantitative Measurement of the Effectiveness of Anti-counterfeiting Technologies
10.3.2.1 Complexity of Factors Influencing Drug Revenue Makes Quantifying Commercial Impact of Anti-counterfeiting Technologies Difficult
10.3.3 Technology Reliability and the Ease of Integration into Manufacturing Processes
10.3.4 Lack of Cooperation Between Governmental Organisations Aid Drug Counterfeiters
10.4 Opportunities
10.4.1 Constantly Evolving Technologies Allows for Product Innovation
10.4.2 Anti-counterfeiting Technologies for the Prevention of Online Fraud
10.5 Threats
10.5.1 High Volume of Counterfeiting Activities Could Devalue Anti-counterfeiting Solutions
10.5.2 Developing Countries Lack Infrastructure to Effectively Deal with Counterfeiting
10.5.3 Rate of Innovation May be Outpaced by Counterfeiters
10.6 STEP Analysis of World Pharmaceutical Anti-counterfeiting Technologies Market 2015-2025
10.7 Social Factors
10.7.1 Weak Enforcement of Legislation
10.7.2 Corruption: A Hindrance to Eradicating Pharmaceutical Counterfeiting
10.7.3 Changing Public Perception and Consumer Education
10.7.4 Concerns Over Information Privacy
10.8 Technological Factors
10.8.1 Smartphone Read and Verify: A Customer Empowerment Tool
10.8.2 US FDA Counterfeit Detection Device
10.8.3 UV and IR Inks Being Used Covertly for Increased Security
10.8.4 Bokode: A Potential Replacement for Barcodes?
10.8.5 SigNature DNA
10.9 Economic Factors
10.9.1 Implementation Costs of Anti-counterfeiting Technologies
10.9.2 Anti-counterfeiting Technologies Require R&D Investment
10.10 Political Factors
10.10.1 WHO: The IMPACT Programme
10.10.2 Anti-Counterfeiting Trade Agreement (ACTA)
10.10.3 The Fagan Civil Case: Effects of Litigation on Players in the Drug Supply Chain
10.10.4 Legislations for Supply Chain Security
10.10.5 E-pedigree: Catalyst for Product Serialisation
10.10.5.1 E-pedigree: Challenges Involved in Implementation
10.10.5.2 EU and US: Differing Supply Chain Authentication
10.10.6 UK MHRA: Falsified Medical Products Strategy
10.10.7 EU’s Falsified Medicines Directive

11. Research Interviews

11.1 Interview with Representatives of Zebra Technologies
11.1.1 Zebra’s Key Technologies and Strategies for Combating Counterfeiters
11.1.2 Country of Largest Counterfeiting Threat
11.1.3 Size and Growth Rate of the Current Pharmaceutical Anti-counterfeiting Technologies Market
11.1.4 Drivers of the Pharmaceutical Anti-counterfeiting Market
11.1.5 Barriers Facing Implementation of Anti-counterfeiting Technologies by Pharma Companies
11.1.6 Most Promising Upcoming Anti-counterfeiting Technology in the Next Decade
11.1.7 Opportunities for Pharma Anti-counterfeiting Technologies Manufacturers
11.2 Interview with Ryon Packer, Chief Marketing Officer and General Manager of Authentix
11.2.1 Authentix’s Key Technologies and Strategies for Combating Counterfeiters
11.2.2 Size and Growth Rate of the Current Pharmaceutical Anti-counterfeiting Technologies Market
11.2.3 Which is Dominating: Barcode or RFID?
11.2.4 Drivers of the Pharmaceutical Anti-counterfeiting Market
11.2.5 Barriers Facing Implementation of Anti-counterfeiting Technologies by Pharma Companies
11.2.6 Most Promising Upcoming Anti-counterfeiting Technology in the Next Decade
11.2.7 Opportunities for Pharma Anti-counterfeiting Technologies Manufacturers
11.3 Interview with Dr Michael Hogan, Vice President of Life Sciences at Applied DNA Sciences
11.3.1 Applied DNA Sciences’ Key Technologies and Strategies for Combating Counterfeiters
11.3.1.1 DNA Labelling Authentication Solution
11.3.1.2 Practicalities of On and In Product DNA Labelling
11.3.2 Applied DNA Sciences Entering the Pharmaceutical Anti-counterfeiting Scene
11.3.3 Current Dominating Anti-Counterfeiting Technology
11.3.4 Most Promising Upcoming Anti-counterfeiting Technology in the Next Decade
11.4 Interview with Mike Messmer, General Manager of NovaVision
11.4.1 NovaVison’s Key Technologies and Strategies for Combating Counterfeiters
11.4.2 Country of Largest Counterfeiting Threat
11.4.3 Size of the Current Pharmaceutical Anti-counterfeiting Technologies Market
11.4.4 Drivers of the Pharmaceutical Anti-counterfeiting Market
11.4.5 Barriers Facing Implementation of Anti-counterfeiting Technologies by Pharma Companies
11.4.6 Most Promising Upcoming Anti-counterfeiting Technology in the Next Decade
11.4.7 Opportunities for Pharma Anti-counterfeiting Technologies Manufacturers
11.5 Interview with Dr Fred Jordan, Chief Executive Officer, AlpVision
11.5.1 Current State of Counterfeiting in the Pharmaceutical Industry
11.5.2 AlpVison’s Key Technologies and Strategies for Combating Counterfeiters
11.5.3 Future of Anti-counterfeiting Technologies
11.5.4 On Whom do the Responsibilities for Counterfeiting Prevention Lie?
11.5.5 Major Barriers Facing Implementation of Anti-counterfeiting Technologies
11.5.6 Future Drivers of the Anti-counterfeiting Technologies Market
11.6 Interview with a Spokesperson from a Leading Anti-counterfeiting Technologies Company Based in the US
11.6.1 Threats Posed by Counterfeit Products
11.6.2 Keeping Up with Counterfeiters: An Impossible Task?
11.6.3 Duty of Care
11.6.4 DNA Technology: Innovation Needed to Defeat Counterfeiting?
11.6.5 Future Prospects of the Pharma Anti-counterfeiting Industry

12. Conclusions

12.1 Pharmaceutical Anti-counterfeiting Technologies: A Growing Market
12.2 Leading Pharmaceutical Anti-counterfeiting Technologies Submarkets in 2014
12.3 Leading National Markets in 2014
12.4 The Future of the Pharmaceutical Anti-counterfeiting Technologies Market?
12.4.1 Government Mandates Will Fuel Growth in the Market
12.4.2 The US Will Continue to Dominate the Market
12.4.3 New Directives Will Ensure Track-and-Trace Market Leadership
12.4.4 European Preference for Mandated 2D Barcode Technology
12.4.5 Enhanced Regulation of Online Pharmacies Necessary for Anti-counterfeiting Technologies to be Effective
12.4.6 Market Expansion Will be Dependent on the Development of Industry-wide Standards
12.4.7 What Will Succeed in the Pharmaceutical Anti-counterfeiting Technologies Market?

13. Glossary

List of Tables

Table 1.1 Leading National Pharmaceutical Anti-counterfeiting Technologies Market Forecast 2015-2025 ($m, AGR%)
Table 2.1 Global Reported Incidents of Drug Counterfeiting, 2009-2013
Table 2.2 Global Reported Incidents of Drug Counterfeiting by Region & Regional Percentage (%), 2013
Table 2.3 Classification of Counterfeit Pharmaceutical Products
Table 2.4 Characteristics of an Ideal Anti-counterfeiting Technology
Table 2.5 Advantages and Disadvantages of Overt and Covert Technologies
Table 2.6 Types of Anti-counterfeiting Technologies Used in the Pharmaceutical Industry by Category
Table 3.1 World Pharmaceutical Anti-counterfeiting Technologies Market: Revenues ($m) by Technology, 2013 and 2014
Table 3.2 World Pharmaceutical Anti-counterfeiting Technologies Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2013-2025
Table 3.3 World Pharmaceutical Anti-counterfeiting Technologies Market Forecast: CAGR (%) by Technology in 2013-2019, 2019-2025 and 2013-2025
Table 3.4 World Pharmaceutical Anti-counterfeiting Technologies: Market Attractiveness Forecast ($m, CAGR%, Market Share%) by Technology, 2019
Table 3.5 World Pharmaceutical Anti-counterfeiting Technologies: Market Attractiveness Forecast ($m, CAGR%, Market Share%) by Technology, 2025
Table 3.6 World Pharmaceutical Anti-counterfeiting Technologies Market Forecast: Market Shares (%) by Technology, 2014, 2019 and 2025
Table 4.1 World Pharmaceutical Anti-counterfeiting Technologies Market: Revenues ($m) by Region, 2013 and 2014
Table 4.2 World Pharmaceutical Anti-counterfeiting Technologies Market Forecast: Revenues ($m), AGR (%), CAGR (%) by Region, 2013-2025
Table 4.3 World Pharmaceutical Anti-counterfeiting Technologies Market Forecast: CAGR (%) by Region in 2013-2019, 2019-2025 and 2013-2025
Table 4.4 World Pharmaceutical Anti-counterfeiting Technologies: Market Attractiveness Forecast ($m, CAGR%, Market Share%) of Developed Countries, 2019 and 2025
Table 4.5 Pharmaceutical Anti-counterfeiting Technologies: Market Attractiveness Forecast ($m, CAGR%, Market Share%) of Emerging Countries, 2019 and 2025
Table 4.6 World Pharmaceutical Anti-counterfeiting Technologies Market Forecast: Market Shares (%) by Region, 2014, 2019 and 2025
Table 4.7 US Pharmaceutical Anti-counterfeiting Technologies Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2013-2025
Table 4.8 Susceptibility of the EU5 Countries to Drug Counterfeiting, 2014
Table 4.9 EU5 Pharmaceutical Anti-counterfeiting Technologies Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2013-2025
Table 4.10 Japanese Pharmaceutical Anti-counterfeiting Technologies Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2013-2025
Table 4.11 Chinese Pharmaceutical Anti-counterfeiting Technologies Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2013-2025
Table 4.12 Indian Pharmaceutical Anti-counterfeiting Technologies Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2013-2025
Table 4.13 Brazilian Pharmaceutical Anti-counterfeiting Technologies Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2013-2025
Table 4.14 Russian Pharmaceutical Anti-counterfeiting Technologies Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2013-2025
Table 4.15 Mexican Pharmaceutical Anti-counterfeiting Technologies Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2013-2025
Table 5.1 Comparison of 2D Barcode and RFID Technology
Table 5.2 Barcodes Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2013-2025
Table 6.1 RFID Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2013-2025
Table 7.1 Taggants Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2013-2025
Table 8.1 Holograms/OVD Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2013-2025
Table 8.2 Other Pharmaceutical Anti-counterfeiting Technologies Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2013-2025
Table 9.1 Leading RFID Technology Manufacturers, 2014
Table 9.2 Leading Holographic Labelling Technology Manufacturers, 2014
Table 9.3 Leading Taggants Technology Manufacturers, 2014
Table 9.4 Other Leading Anti-counterfeiting Technology Manufacturers, 2014
Table 9.5 3M: Revenue ($m) and Revenue Shares (%) by Business Segment, 2013
Table 9.6 3M Historical Sales: Revenue ($m), AGR (%), 2009-2013
Table 9.7 Alien Technologies: Portfolio of RFID Readers, 2014
Table 9.8 Alien Technologies: Portfolio of RFID Inlays and Their Relative Performances in Pharma Applications, 2014
Table 9.9 AlpVision: Portfolio of Pharmaceutical Anti-counterfeiting Solutions, 2014
Table 9.10 Angstrom Technologies: Portfolio of Anti-counterfeiting Solutions, 2014
Table 9.11 Avery Dennison: Portfolio of RFID Inlays for Use in Pharmaceuticals, 2014
Table 9.12 Avery Dennison: Revenue ($m) and Revenue Shares (%) by Business Segment, 2013
Table 9.13 Avery Dennison Historical Sales: Revenue ($m), AGR (%), 2009-2013
Table 9.14 Colorcon: Portfolio of Product Groups, Sub-groups, and Examples, 2014
Table 9.15 Everest Holovision: Portfolio of Products and Applications, 2014
Table 9.16 InkSure Technologies: Portfolio of Products and Applications, 2014
Table 9.17 InkSure Technologies Historical Sales: Revenue ($m), AGR (%), 2009-2013
Table 9.18 Intermec: Portfolio of Products and Descriptions, 2014
Table 9.19 Honeywell (acquired Intermec in 2013) Historical Sales: Revenue ($m), AGR (%), 2009-2013
Table 9.20 ThermoFisher Scientific Historical Sales: Revenue ($m), AGR (%), 2009-2013
Table 9.21 ThermoFisher Scientific: Revenues ($m), Revenue Shares (%) by Business Segment, 2013
Table 9.22 UPM Raflatac: Portfolio of Product Groups and Descriptions, 2014
Table 9.23 Zebra Technologies: Portfolio of Product Groups and Descriptions, 2014
Table 9.24 Zebra Technologies Historical Sales: Revenue ($m), AGR (%), 2009-2013
Table 10.1 SWOT Analysis of World Pharmaceutical Anti-counterfeiting Technologies Market, 2015-2025
Table 10.2 Selected Instances of Counterfeiting Activities, 2009-2014
Table 10.3 STEP Analysis of World Pharmaceutical Anti-counterfeiting Technologies Market, 2015-2025

List of Figures

Figure 1.1 Global Reported Incidents of Drug Counterfeiting, 2009-2013
Figure 1.2 World Anti-counterfeiting Market Segmentation by Technology Overview
Figure 1.3 World Anti-counterfeiting Market Segmentation by Region Overview
Figure 2.1 Global Reported Incidents of Drug Counterfeiting, 2009-2013
Figure 2.2 Global Reported Incidents of Drug Counterfeiting by Region, 2013
Figure 2.3 Global Reported Incidents of Drug Counterfeiting by Regional Percentage (%), 2013
Figure 2.4 Most Common Types of Drugs Counterfeited in Developed and Emerging Countries, 2014
Figure 2.5 Flow Chart of the Route Taken by Counterfeit Pharma Products Entering the Legal Supply Chain
Figure 2.6 Basic Components of a RFID System
Figure 3.1 World Pharmaceutical Anti-counterfeiting Technologies Market: Revenues ($m) by Technology, 2013
Figure 3.2 World Pharmaceutical Anti-counterfeiting Technologies Market: Revenues ($m) by Technology, 2014
Figure 3.3 World Pharmaceutical Anti-counterfeiting Technologies Market Forecast: Revenue ($m), AGR (%), 2013-2025
Figure 3.4 World Pharmaceutical Anti-counterfeiting Technologies Market: Revenues ($m) by Technology, 2013-2025
Figure 3.5 World Pharmaceutical Anti-counterfeiting Market Forecast: Revenue ($m), CAGR (%), by Technology 2013 and 2025
Figure 3.6 World Pharmaceutical Anti-counterfeiting Market Forecast: CAGR (%) by Technology in 2013-2019 and 2019-2025
Figure 3.7 World Pharmaceutical Anti-counterfeiting Market Forecast: CAGR (%) by Technology in 2013-2025
Figure 3.8 World Pharmaceutical Anti-counterfeiting Technologies: Market Attractiveness Forecast ($m, CAGR%) by Technology, 2019
Figure 3.9 World Pharmaceutical Anti-counterfeiting Technologies: Market Attractiveness Forecast ($m, CAGR%) by Technology, 2025
Figure 3.10 World Pharmaceutical Anti-counterfeiting Technologies Market: Market Shares (%) by Technology, 2014
Figure 3.11 World Pharmaceutical Anti-counterfeiting Technologies Market: Market Shares (%) by Technology, 2019
Figure 3.12 World Pharmaceutical Anti-counterfeiting Technologies Market: Market Shares (%) by Technology, 2025
Figure 3.13 World Pharmaceutical Anti-counterfeiting Technologies Market: Drivers and Restraints, 2015-2025
Figure 4.1 World Pharmaceutical Anti-counterfeiting Technologies Market: Revenues ($m) by Region, 2013
Figure 4.2 World Pharmaceutical Anti-counterfeiting Technologies Market: Revenues ($m) by Region, 2014
Figure 4.3 World Pharmaceutical Anti-counterfeiting Technologies Market: Revenues ($m) by Region, 2013-2025
Figure 4.4 World Pharmaceutical Anti-counterfeiting Technologies Market Forecast: Revenue ($m), CAGR (%), by Region, 2013 and 2025
Figure 4.5 World Pharmaceutical Anti-counterfeiting Market Forecast: CAGR (%) by Region in 2013-2019 and 2019-2025
Figure 4.6 World Pharmaceutical Anti-counterfeiting Market Forecast: CAGR (%) by Region in 2013-2025
Figure 4.7 World Pharmaceutical Anti-counterfeiting Technologies: Markets Attractiveness Forecast ($m, CAGR%) of Developed Countries, 2019
Figure 4.8 World Pharmaceutical Anti-counterfeiting Technologies: Markets Attractiveness Forecast ($m, CAGR%) of Developed Countries, 2025
Figure 4.9 World Pharmaceutical Anti-counterfeiting Technologies: Markets Attractiveness Forecast ($m, CAGR%) of Emerging Countries, 2019
Figure 4.10 World Pharmaceutical Anti-counterfeiting Technologies: Markets Attractiveness Forecast ($m, CAGR%) of Emerging Countries, 2025
Figure 4.11 World Pharmaceutical Anti-counterfeiting Technologies Market: Market Shares (%) by Region, 2014
Figure 4.12 World Pharmaceutical Anti-counterfeiting Technologies Market: Market Shares (%) by Region, 2019
Figure 4.13 World Pharmaceutical Anti-counterfeiting Technologies Market: Market Shares (%) by Region, 2025
Figure 4.14 US Pharmaceutical Anti-counterfeiting Technologies Market Forecast: Revenues ($m), AGR (%), 2013-2025
Figure 4.15 EU5 Pharmaceutical Anti-counterfeiting Technologies Market Forecast: Revenues ($m), AGR (%), 2013-2025
Figure 4.16 Japanese Pharmaceutical Anti-counterfeiting Technologies Market Forecast: Revenues ($m), AGR (%), 2013-2025
Figure 4.17 Chinese Pharmaceutical Anti-counterfeiting Technologies Market Forecast: Revenues ($m), AGR (%), 2013-2025
Figure 4.18 Indian Pharmaceutical Anti-counterfeiting Technologies Market Forecast: Revenues ($m), AGR (%), 2013-2025
Figure 4.19 Brazilian Pharmaceutical Anti-counterfeiting Technologies Market Forecast: Revenues ($m), AGR (%), 2013-2025
Figure 4.20 Russian Pharmaceutical Anti-counterfeiting Technologies Market Forecast: Revenues ($m), AGR (%), 2013-2025
Figure 4.21 Mexican Pharmaceutical Anti-counterfeiting Technologies Market Forecast: Revenues ($m), AGR (%), 2013-2025
Figure 5.1 Barcodes Market Forecast: Revenues ($m), AGR (%), 2013-2025
Figure 5.2 Barcodes Market Forecast: Drivers and Restraints, 2015-2025
Figure 6.1 RFID Market Forecast: Revenues ($m), AGR (%), 2013-2025
Figure 6.2 RFID Market Forecast: Drivers and Restraints, 2015-2025
Figure 7.1 Taggants Market Forecast: Revenues ($m), AGR (%), 2013-2025
Figure 7.2 Taggants Market Forecast: Drivers and Restraints, 2015-2025
Figure 8.1 Holograms/OVD Market Forecast: Revenues ($m), AGR (%), 2013-2025
Figure 8.2 Holograms/OVD Market Forecast: Drivers and Restraints, 2015-2025
Figure 8.3 Other Pharmaceutical Anti-counterfeiting Technologies Market Forecast: Revenues ($m), AGR (%), 2013-2025
Figure 9.1 3M: Revenue Shares (%) by Business Segment, 2013
Figure 9.2 3M Historical Sales: Revenue ($m), AGR (%), 2009-2013
Figure 9.3 Authentix’s Global Monitoring Service: A Three Step Programme
Figure 9.4 Avery Dennison: Revenue Shares (%) by Business Segment, 2013
Figure 9.5 Avery Dennison Historical Sales: Revenue ($m), AGR (%), 2009-2013
Figure 9.6 InkSure Technologies Historical Sales: Revenue ($m), AGR (%), 2009-2013
Figure 9.7 Honeywell (acquired Intermec in 2013) Historical Sales: Revenue ($m), AGR (%), 2009-2013
Figure 9.8 ThermoFisher Scientific Historical Sales: Revenue ($bn), AGR (%), 2009-2013
Figure 9.9 ThermoFisher Scientific: Revenue Shares (%) by Business Segment, 2013
Figure 9.10 Zebra Technologies Historical Sales: Revenue ($m), AGR (%), 2009-2013
Figure 10.1 EU Supply Chain Authentication Strategy, 2014
Figure 10.2 US Supply Chain Authentication Strategy, 2014
Figure 12.1 Top Five National Pharmaceutical Anti-counterfeiting Technologies Markets: Revenues ($m), 2014 & 2025

掲載企業リスト

Companies Listed

3M
Adhesives Research
Ahura Scientific
Alien Technology
AlpVision
Amerisource
AmerisourceBergen (Amgen)
AND Automation
Angstrom Technologies
Angstrom Technologies
Apoteket
Applied DNA Sciences
ARmark Authentication Technologies
AstraZeneca
Authentix
Avery Dennison
Axway
Baxter
Cal Sierra
Camdata
Cardinal Health
Cellular Bioengineering
CFC International
Colorcon
Cortegra
Covectra
DataDot Technology
DataTrace DNA
Digital China
Domino
DuPont
Everest Holovisions
Genentech
GIS
GlaxoSmithKline (GSK)
Hart Systems
Hoffmann-La Roche
Hologram Industries
Holomex
Holovisions
Honeywell
Image Solutions
Impinj
Ingenia Technology
Inksure Technologies
Intermec Technologies
International Ink Company
Johnson & Johnson (J&J)
Kodak
LaserLock
Life Technologies
McKesson
Menasha Corporation
MicroTag Temed
Microtrace Solutions
Millennium Pharmaceuticals
Motorola
Multi Packaging Solutions (formerly Chesapeake)
Nanotech Security Corp
Neri Labels
Novartis
Novavision
OEP Technologie BV
Pacific Holographics
Pera Innovation
Pfizer
ROC IT Solutions
Roche
Sanofi
SciClone
Shanghai Ruizhang Investment
SICPA
Siemens
Smartrac
Spectra Systems Corporation
Sun Chemical
Symbol Technologies
Systech
Tagsys RFID
Texas Instruments
The Carlyle Group
ThermoFisher Scientific
TruTag Technologies
UPM Raflatac
UPM-Kymmene Corporation
Voxtel
Webscan
WuXi PharmaTech
Zebra Technologies

Other Organisations Mentioned in this Report

Agência Nacional de Vigilância Sanitária (ANVISA)
American Academy of Paediatrics (AAP)
Anti-counterfeiting Drug Research Institute (IRACM)
Anti-counterfeiting Group (ACG)
Australian Therapeutic Goods Administration (TGA)
British Medicines and Healthcare Products Regulatory Agency (MHRA)
Canadian Anti-counterfeiting Network (CACN)
Centre for Healthcare Supply Chain Research
China Anti-Counterfeiting Technology Association (CATA)
China Food and Drug Administration (CFDA)
China Trade Association for Anti-Counterfeiting (CTAAC)
China's Ministry of Public Security (MPS)
Chinese Quality Brands Protection Committee (QBPC)
Council of Europe
Drugs Standard Control Organisation (DSC)
Europe’s Medicrime Convention Council
European Alliance for Access to Safe Medicines (EAASM)
European Directorate for the Quality of Medicines and Healthcare (EDQM)
European Federation of Pharmaceutical Industries and Associations (EFPIA)
European Medicines Agency
Federal System of Control of Medication (SNCM)
Food and Drug Administration (FDA)
Healthcare Distribution Management Association (HDMA)
Holograms Manufactures Association of India (HOMAI)
Indian Directorate General of Foreign Trade (DGFT)
International Anti-counterfeiting Coalition (IACC)
International Authentication Association (IAA)
International Criminal Police Organization (INTERPOL)
International Federation of Pharmaceutical Manufacturers & Associations (IFPMA)
International Hologram Manufacturers Association (IHMA)
International Organization for Standardization (ISO)
International Policy Network (IPN)
Japanese Pharmaceutical Manufacturers Association (JPMA)
Loughborough University
Massachusetts Institute of Technology (MIT)
National Agency for Food and Drug Administration and Control (NAFDAC)
National Associations of Boards of Pharmacy (NABP).
National Health Surveillance Agency (ANVISA)
OpSec Security
Organisation for Economic Co-operation and Development (OECD)
Partner for Safe Medicines (PSM)
Patients Association
Pharmaceutical Research and Manufacturers of America (PhRMA)
Pharmaceutical Security Institute (PSI)
Royal Pharmaceutical Society of Great Britain (RPSGB)
Russian Economic Development Ministry
Russian Ministry of Health
South Dakota School of Mines and Technology
University of South Dakota
US Centre for Safe Internet Pharmacies (CSIP)
World Customs Organization (WCO)
World Health Organization (WHO)
World Intellectual Property Organisation (WIPO)

プレスリリース

プレスリリース

Memo.png当レポートのプレスリリースは発行されておりません。

2319881.jpg国内外のスマートグリッド関連ニュース、リサーチ情報等を収集し隔週でお届けいたします。日本そして海外の企業動向、新製品、政府支援、技術開発、規格、導入事例、投資、調査発表など幅広く情報を定期配信いたします。
スマートグリッド・ニュースへLinkIcon


ニュースページへLinkIcon

資料検索

お探しの資料・レポートをキーワードで検索ください。

当サイト内の検索結果が表示されます。調査レポートは英文目次を掲載しているため、英語検索も有効です。
(ブラウザのスクリプトを有効にしないとサーチエンジンが表示されません)

お問い合わせ

2714110_0.jpg
レポートをお探しいたします。
当サイトに掲載されているレポート以外にも幅広くご提案可能です。レポートの内容に関するご質問、ご確認にも回答いたします。お気軽にお問い合わせください。